Interleukin 2: From immunostimulation to immunoregulation and back again

EMBO Reports

Volumn 8, Issue 12, 2007, Pages 1142-1148

  Bachmann, Martin F ^a   Oxenius, Annette ^b  

^a CYTOS BIOTECHNOLOGY AG   (Switzerland)

^b ETH ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; FAS LIGAND; FK 506 BINDING PROTEIN; FLICE INHIBITORY PROTEIN; GAMMA INTERFERON; INTERLEUKIN 15; INTERLEUKIN 15 RECEPTOR; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 2 RECEPTOR BETA; INTERLEUKIN 2 RECEPTOR GAMMA; JANUS KINASE 1; JANUS KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BCL 2; PROTEIN KINASE B; PROTEIN KINASE LCK; PROTEIN KINASE SYK; RAF PROTEIN; RAS PROTEIN; S6 KINASE; STAT5 PROTEIN; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE; CELL GROWTH; CLONAL ANERGY; CYTOKINE RELEASE; ENZYME ACTIVATION; GENE MUTATION; HUMAN; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; IMMUNOSTIMULATION; INNATE IMMUNITY; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; LYMPHOPROLIFERATIVE DISEASE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; VIRUS IMMUNITY;

ANIMALS; HUMANS; IMMUNITY, ACTIVE; IMMUNIZATION; INTERLEUKIN-2; MODELS, BIOLOGICAL; T-LYMPHOCYTES;

EID: 36749041328     PISSN: 1469221X     EISSN: 14693178     Source Type: Journal    
DOI: 10.1038/sj.embor.7401099     Document Type: Review

References (83)

1. Abbas AK (2003) The control of T cell activation vs. tolerance. Autoimmun Rev 2: 115-118
2. + T cell functions during chronic viral infection. Proc Natl Acad Sci USA 104: 4565-4570
3. Bachmann MF, Kopf M (2002) Balancing protective immunity and immunopathology. Curr Opin Immunol 14: 413-419
4. Bachmann MF, Schorle H, Kuhn R, Muller W, Hengartner H, Zinkernagel RM, Horak I (1995) Antiviral immune responses in mice deficient for both interleukin-2 and interleukin-4. J Virol 69: 4842-4846
5. + T cells. J Immunol 173: 2217-2221
6. + T cells and antiviral protection. J Immunol 175: 4677-4685
7. Bachmann MF, Wolint P, Walton S, Schwarz K, Oxenius A (2007) Differential role of IL-2R signaling for CD8(+)T cell responses in acute and chronic viral infections. Eur J Immunol 37: 1502-1512
8. Bamford RN, Grant AJ, Burton JD, Peters C, Kurys G, Goldman CK, Brennan J, Roessler E, Waldmann TA (1994) The interleukin (IL) 2 receptor beta chain is shared by IL-2 and a cytokine, provisionally designated IL-T, that stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. Proc Natl Acad Sci USA 91 4940-4944
9. Blattman JN, Grayson JM, Wherry EJ, Kaech SM, Smith KA, Ahmed R (2003) Therapeutic use of IL-2 to enhance antiviral T-cell responses in vivo. Nat Med 9: 540-547
10. Boyman O, Kovar M, Rubinstein MP, Surh CD, Sprent J (2006) Selective stimulation of T cell subsets with antibody-cytokine immune complexes. Science 311: 1924-1927
11. Brunkow ME, Jeffery EW, Hjerrild KA, Paeper B, Clark LB, Yasayko SA, Wilkinson JE, Galas D, Ziegler SF, Ramsdell F (2001) Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet 27 68-73
12. Brunner T et al (1995) Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 373: 441-444
13. + T cell homeostasis. J Exp Med 200: 825-834
14. + cells driven by IL-2. J Exp Med 204: 1787-1801
15. Cornish GH, Sinclair LV, Cantrell DA (2006) Differential regulation of T-cell growth by IL-2 and IL-15. Blood 108: 600-608
16. Cousens LP, Orange J5, Biron CA (1995) Endogenous IL-2 contributes to T cell expansion and IFN-γ production during lymphocytic choriomeningitis virus infection. J Immunol 155: 5690-5699
17. + regulatory T cells in the absence of interleukin 2 signaling. Nat Immunol 6: 1152-1159
18. D'Souza WN, Lefrancois L (2003) IL-2 is not required for the initiation of CD8 T cell cycling but sustains expansion. J Immunol 171: 5727-5735
19. D'Souza WN, Schluns KS, Masopust D, Lefrancois L (2002) Essential role for IL-2 in the regulation of antiviral extralymphoid CD8 T cell responses. J Immunol 168: 5566-5572
20. + T cell death. J Immunol 163: 3131-3137
21. + memory T cells. J Immunol 165: 3031-3036
22. Dhein J, Walczak H, Baumler C, Debatin KM, Krammer PH (1995) Autocrine T-cell suicide mediated by APO-1 AFas/CD95). Nature 373: 438-441
23. + T cell memory by promoting the generation of IL-7R α-expressing cells. J Exp Med 204: 547-557
24. Dubois S, Mariner J, Waldmann TA, Tagaya Y (2002) IL-15Rα recycles and presents IL-15 in trans to neighboring cells. Immunity 17 537-547
25. Dubois S, Shou W, Haneline LS, Fleischer S, Waldmann TA, Muller JR (2003) Distinct pathways involving the FK506-binding proteins 12 and 12.6 underlie IL-2-versus IL-15-mediated proliferation of T cells. Proc Natl Acad Sci USA 100: 14169-14174
26. + regulatory T cells. Nat Immunol 4 330-336
27. Fontenot JD, Rasmussen JP, Gavin MA, Rudensky AY (2005) A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat Immunol 6: 1142-1151
28. Gillis S, Smith KA (1977) Long term culture of tumour-specific cytotoxic T cells. Nature 268: 154-156
29. Gillis S, Baker PE, Ruscetti FW, Smith KA (1978) Long-term culture of human antigen-specific cytotoxic T-cell lines. J Exp Med 148 1093-1098
30. + T lymphocytes. Nature 421: 852-856
31. + T-cell memory via TRAIL-mediated activation-induced cell death. Nature 434: 88-93
32. Ju ST, Planka DJ, Cui H, Ettinger R, el-Khatib M, Sherr DH, Stanger BZ, Marshak-Rothstein A (1995) Fas(CD95)/FasL interactions required for programmed cell death after-cell activation. Nature 373: 444-448
33. + T cells differentiate into protective memory-like cells after IL-2 anti IL-2 complex treatment in vivo. J Exp Med 204: 1803-1812
34. + cytotoxic T lymphocytes. J Exp Med 187: 49-57
35. Keene JA, Forman J (1982) Helper activity is required for the in vivo generation of cytotoxic T lymphocytes. J Exp Med 155: 768-782
36. Khoruts A, Mondino A, Pape KA, Reiner SL, Jenkins MK (1998) A natural immunological adjuvant enhances T cell clonal expansion through a CD28-dependent, interleukin (IL)-2-independent mechanism. J Exp Med 187: 225-236
37. Klebb G, Autenrieth IB, Haber H, Gillert E, Sadlack B, Smith KA, Horak I (1996) Interleukin-2 is indispensable for development of immunological self-tolerance. Clin Immunol Immunopathol 81: 282-286
38. Kneitz B, Herrmann T, Yonehara S, Schimpl A (1995) Normal clonal expansion but impaired Fas-mediated cell death and anergy induction in interleukin-2-deficient mice. Eur J Immunol 25: 2572-2577
39. Kovanen PE, Leonard WJ (2004) Cytokines and immunodeficiency diseases: critical roles of the γ(c)-dependent cytokines interleukins 2, 4, 7, 9, 15, and 21, and their signaling pathways. Immunol Rev 202: 67-83
40. Kramer S, Mamalaki C, Horak I, Schimpl A, Kioussis D, Hung T (1994) Thymic selection and peptide-induced activation of T cell receptor-transgenic CD8 T cells in interleukin-2-deficient mice. Eur J Immunol 24: 2317-2322
41. Krammer PH (2000) CD95s deadly mission in the immune system. Nature 407: 789-795
42. + memory T cells by opposing cytokines. Science 288: 675-678
43. Kündig T, Schorle H, Bachmann MF, Hengartner H, Zinkernagel RM, Horak I (1993) Immune responses in interleukin-2 deficient mice. Science 262: 1059-1061
44. Kündig TM, Shahinian A, Kawai K, Mittrücker HW, Sebzda E, Bachmann MF, Mak TW, Ohashi PS (1996) Duration of TCR stimulation determines costimulatory requirement of T cells. Immunity 5: 41-52
45. Laurence A et al (2007) Interleukin-2 signaling via STATS constrains T helper 17 cell generation. Immunity 26: 371-381
46. Lenardo MJ (1991) Interleukin-2 programs mouse αβ T lymphocytes for apoptosis. Nature 353: 858-861
47. Leonard WJ et al (1984) Molecular cloning and expression of cDNAs for the human interleukin-2 receptor. Nature 311: 626-631
48. Ma A, Koka R, Burkett P (2006) Diverse functions of IL-2, IL-15, and IL-7 in lymphoid homeostasis. Annu Rev Immunol 24: 657-679
49. Malek TR, Porter BO, Codias EK, Scibelli P, Yu A (2000) Normal lymphoid homeostasis and lack of lethal autoimmunity in mice containing mature T cells with severely impaired IL-2 receptors. J Immunol 164: 2905-2914
50. Malek TR, Yu A, Scibelli P, Lichtenheld MG, Codias EK (2001) Broad programming by IL-2 receptor signaling for extended growth to multiple cytokines and functional maturation of antigen-activated T cells. J Immunol 166: 1675-1683
51. Malek TR, Yu A, Vincek V, Scibelli P, Kong L (2002) CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rβ-deficient mice. Implications for the nonredundant function of IL-2. Immunity 17 167-178
52. Miyazaki T, Liu ZJ, Kawahara A, Minami Y, Yamada K, Tsujimoto Y, Barsoumian EL, Permutter RM, Taniguchi T (1995) Three distinct IL-2 signaling pathways mediated by bcl-2, c-myc, and lck cooperate in hematopoietic cell proliferation. Cell 81: 223-231
53. Morgan DA, Ruscetti FW, Gallo RC (1976) Selective in vitro growth of T lymphocytes from normal human bone marrow. Science 193: 1007-1009
54. Nikaido T, Shimizu A, Ishida N, Sabe H, Teshigawara K, Maeda M, Uchiyama T, Yodoi J, Honjo T (1984) Molecular cloning of cDNA encoding human interleukin-2 receptor. Nature 311: 631-635
55. Northrop JK, Thomas RM, Wells AD, Shen H (2006) Epigenetic remodeling of the IL-2 and IFN-γ loci in memory CD8 T cells is influenced by CD4 T cells. J Immunol 177: 1062-1069
56. Papiernik M, de Moraes ML, Pontoux C,Vasseur F, Penit C (1998) Regulatory CD4 T cells: Expression of IL-2R a chain, resistance to clonal deletion and IL-2 dependency. Int Immunol 10: 371-378
57. Powell JD, Ragheb JA, Kitagawa-Sakakida S, Schwartz RH (1998) Molecular regulation of interleukin-2 expression by CD28 co-stimulation and anergy. Immunol Rev 165: 287-300
58. Refaeli Y, Van Parijs L, London CA, Tschopp J, Abbas AK (1998) Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis. Immunity 8: 615-623
59. Sadlack B, Merz H, Schorle H, Schimpl A, Feller AC, Horak I (1993) Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 75: 253-261
60. Sandau MM, Schluns KS, Lefrancois L, Jameson SC (2004) Cutting edge: transpresentation of IL-15 by bone marrow-derived cells necessitates expression of IL-15 and IL-15R α by the same cells. J Immunol 173: 6537-6541
61. Schimpl A, Berberich I, Kneitz B, Kramer S, Santner-Nanan B, Wagner S, Wolf M, Hunig T (2002) IL-2 and autoimmune disease. Cytokine Growth Factor Rev 13: 369-378
62. Schorle H, Holtschke T, Hunig T, Schimpl A, Horak I (1991) Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting. Nature 352: 621-624
63. Schwartz RH (11996) Models of T cell anergy: Is there a common molecular mechanism? J Exp Med 184: 1-8
64. Schwartz RH (2003) T cell anergy. Annu Rev Immunol 21: 305-334
65. Shedlock DJ, Shen H (2003) Requirement for CD4 T cell help in generating functional CD8T cell memory. Science 300: 337-339
66. Smith KA (1988) Interleukin-2: Inception, impact, and implications. Science 240: 1169-1176
67. Smith KA, Gilbride KJ, Favata MF (1980) Lymphocyte activating factor promotes T-cell growth factor production by cloned murine lymphoma cells. Nature 287: 853-855
68. Sun JC, Bevan MJ (2003) Defective CD8T cell memory following acute infection without CD4 T cell help. Science 300: 339-342
69. Suzuki H et al (1995) Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor β. Science 268: 1472-1476
70. Suzuki H, Zhou YW, Kato M, Mak TW, Nakashima I (1999) Normal regulatory a/β T cells effectively eliminate abnormally activated T cells lacking the interleukin 2 receptor β in vivo. J Exp Med 190: 1561-1572
71. Taniguchi T, Matsui H, Fujita T, Takaoka C, Kashima N, Yoshimoto R, Hamuro J (1983) Structure and expression of a cloned cDNA for human interleukin-2. Nature 302: 305-310
72. Thomas RM, Gao L, Wells AD (2005) Signals from CD28 induce stable epigenetic modification of the IL-2 promoter. J Immunol 174: 4639-4646
73. Utermohlen O, Tarnok A, Bonig L, Lehmann-Grube F (1994) T lymphocyte-mediated antiviral immune responses in mice are diminished by treatment with monoclonal antibody directed against the interleukin-2 receptor. Eur J Immunol 24: 3093-3099
74. Van Parijs L, Biuckians A, Ibragimov A, Alt FW, Willerford DM, Abbas AK (1997) Functional responses and apoptosis of CD25 (IL-2R α -deficient T cells expressing a transgenic antigen receptor. J Immunol 158 3738-3745
75. Van Parijs L, Biuckians A, Abbas AK (1998) Functional roles of Fas and Bcl-2-regulated apoptosis of T lymphocytes. J Immunol 160: 2065-2071
76. Vezys V, Masopust D, Kemball CC, Barber DL, O'Mara LA, Larsen CP, Pearson TC, Ahmed R, Lukacher AE (2006) Continuous recruitment of naive T cells contributes to heterogeneity of antiviral CD8T cells during persistent infection. J Exp Med 203: 2263-2269
77. Waldmann TA (2006) The biology of interieukin-2 and interleukin-15: implications for cancer therapy and vaccine design. Nat Rev Immunol 6: 595-601
78. Waldmann TA, Dubois S, Tagaya Y (2001) Contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes: Implications for immunotherapy. Immunity 14: 105-110
79. Willerford DM, Chen J, Ferry JA, Davidson L, Ma A, Alt FW (1995) Interleukin-2 receptor α chain regulates the size and content of the peripheral lymphoid compartment. Immunity 3: 521-530
80. + memory T cells. Nature 441: 890-893
81. Wolf M, Schimpl A, Hunig T (2001) Control of T cell hyperactivation in IL-2-deficient mice by CD4(+)CD25(-) and CD4(+)CD25(+) T cells: Evidence for two distinct regulatory mechanisms. Eur J Immunol 31: 1637-1645
82. Yu A, Zhou J, Marten N, Bergmann CC, Mammolenti M, Levy RB, Malek TR (2003) Efficient induction of primary and secondary T cell-dependent immune responses in vivo in the absence of functional IL-2 and IL-15 receptors. J Immunol 170: 236-242
83. Zheng L, Trageser CL, Willerford DM, Lenardo MJ (1998) T cell growth cytokines cause the superinduction of molecules mediating antigen-induced T lymphocyte death. J Immunol 160: 763-769